Literature DB >> 7728403

Epidemiology and mortality in 220 patients with polymyalgia rheumatica.

C Schaufelberger1, B A Bengtsson, R Andersson.   

Abstract

Between 1985 and 1987 a total of 521 people underwent temporal artery biopsy with no histological evidence of arteritis in Göteborg, Sweden. Two-hundred-and-twenty people were diagnosed as having polymyalgia rheumatica (PMR). Among the patients without PMR 30% had rheumatic, 17% malignant and 14% infectious disorders. The annual incidence of PMR with negative biopsy was 17/100,000 and for the population over 50 yr it was 50/100,000. We found an increased mortality in vascular diseases among men with PMR in the first 2 yr after diagnosis with 13 observed deaths compared to the expected six (P < 0.01). There was also a tendency toward an increased mortality among the women with 16 observed deaths compared to the expected 11 (not statistically significant). The mortality in malignant diseases was not increased.

Entities:  

Mesh:

Year:  1995        PMID: 7728403     DOI: 10.1093/rheumatology/34.3.261

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  16 in total

Review 1.  Giant cell arteritis and polymyalgia rheumatica: pathophysiology and management.

Authors:  Miguel A Gonzalez-Gay; Carlos Garcia-Porrua; Jose A Miranda-Filloy; Javier Martin
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

2.  FUO and biopsy-negative GCA.

Authors:  Oscar M P Jolobe
Journal:  J Gen Intern Med       Date:  2009-07       Impact factor: 5.128

3.  Giant cell arteritis and cardiovascular disease in older adults.

Authors:  J G Ray; M M Mamdani; W H Geerts
Journal:  Heart       Date:  2005-03       Impact factor: 5.994

4.  Diagnostic performance of ¹⁸F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a systematic review and meta-analysis.

Authors:  Florent L Besson; Jean-Jacques Parienti; Boris Bienvenu; John O Prior; Sylvie Costo; Gerard Bouvard; Denis Agostini
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-05-11       Impact factor: 9.236

5.  Do steroids increase lymphoma risk? A case-control study of lymphoma risk in polymyalgia rheumatica/giant cell arteritis.

Authors:  J Askling; L Klareskog; H Hjalgrim; E Baecklund; M Björkholm; A Ekbom
Journal:  Ann Rheum Dis       Date:  2005-04-20       Impact factor: 19.103

6.  Prevalence of polymyalgia rheumatica in Colombia: data from the national health registry 2012-2016.

Authors:  Daniel G Fernández-Ávila; Santiago Bernal-Macías; Diana N Rincón-Riaño; Juan M Gutiérrez; Diego Rosselli
Journal:  Rheumatol Int       Date:  2019-07-20       Impact factor: 2.631

7.  Mortality risk associated with rheumatoid arthritis in a prospective cohort of older women: results from the Iowa Women's Health Study.

Authors:  T R Mikuls; K G Saag; L A Criswell; L A Merlino; R A Kaslow; B J Shelton; J R Cerhan
Journal:  Ann Rheum Dis       Date:  2002-11       Impact factor: 19.103

8.  Epidemiology of Polymyalgia Rheumatica 2000-2014 and Examination of Incidence and Survival Trends Over 45 Years: A Population-Based Study.

Authors:  Shafay Raheel; Izzat Shbeeb; Cynthia S Crowson; Eric L Matteson
Journal:  Arthritis Care Res (Hoboken)       Date:  2017-07-10       Impact factor: 4.794

Review 9.  [Polymyalgia rheumatica: What is the current status?].

Authors:  M Seitz
Journal:  Z Rheumatol       Date:  2015-08       Impact factor: 1.372

10.  An uneven expression of T cell receptor V genes in the arterial wall and peripheral blood in giant cell arteritis.

Authors:  C Schaufelberger; R Andersson; E Nordborg; G K Hansson; C Nordborg; J Wahlström
Journal:  Inflammation       Date:  2008-12       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.